EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Prognostic features of the tumor microenvironment in high-grade serous ovarian cancer and dietary immunomodulation

Nathalie D McKenzie, Sarfraz Ahmad, Ahmad Awada, Theresa M Kuhn, Fernando O Recio, Robert W Holloway

Life Sciences · 2023

DOI: 10.1016/j.lfs.2023.122178 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Life Sciences, 2023. Verfasst von Nathalie D McKenzie und 5 weiteren Autor:innen. Beteiligte Einrichtung: AdventHealth Cancer Institute, Gynecologic Oncology Program, Orlando, FL 32804, USA. Electronic address: nathalie.mckenzie.MD@adventhealth.com. Hauptthemen laut MEDLINE: Tumor Microenvironment, Ovarian Neoplasms. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 54 Literaturangaben. Gefördert von: AdventHealth Orlando.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

High-grade serous ovarian cancer (HGSOC) is a particularly lethal malignancy that is prognostically influenced by the immune profile of the tumor microenvironment (TME). TME immune profiles have been sub-categorized according to features associated with both survival outcomes as well as response to systemic therapies. Five suggested immune phenotypes have been described and correlated with overall survival outcomes. Phenotypes associated with shorter overall survival rates appear to have prominent immunosuppressive features within their TME. The opportunity to triage patients according to their prognostic TME profile might allow selection of individual patients with poor prognostic features who could most benefit from innovative immunomodulatory treatment strategies. Two potential strategies to indirectly manipulate the TME (and oncologic outcomes) are alteration of the gut microbiome composition and alteration of TME metabolism through dietary interventions. Experimental dietary modifications in humans designed for influencing cancer outcomes are only beginning to be studied in a prospective fashion. Herein we summarize prognostic TME features in HGSOC and potential opportunities for immunomodulation via dietary and gut microbial interventions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tumor MicroenvironmentOvarian NeoplasmsHumansFemalePrognosisImmunomodulationImmunity

Stichwörter der Autor:innen

ImmunomodulationOvarian cancerPrognosisTreatment responseTumor metabolismTumor microenvironment

Autor:innen und Institutionen

  • AdventHealth Cancer Institute, Gynecologic Oncology Program, Orlando, FL 32804, USA. Electronic address: nathalie.mckenzie.MD@adventhealth.com.
  • AdventHealth Cancer Institute, Gynecologic Oncology Program, Orlando, FL 32804, USA. Electronic address: sarfraz.ahmad@adventhealth.com.
  • AdventHealth Cancer Institute, Gynecologic Oncology Program, Orlando, FL 32804, USA.

Förderung

  • AdventHealth Orlando

Zitieren

APA

McKenzie, N. D., Ahmad, S., Awada, A., Kuhn, T. M., Recio, F. O., & Holloway, R. W. (2023). Prognostic features of the tumor microenvironment in high-grade serous ovarian cancer and dietary immunomodulation. Life Sciences. https://doi.org/10.1016/j.lfs.2023.122178

Vancouver

McKenzie ND, Ahmad S, Awada A, Kuhn TM, Recio FO, Holloway RW. Prognostic features of the tumor microenvironment in high-grade serous ovarian cancer and dietary immunomodulation. Life Sciences. 2023. doi:10.1016/j.lfs.2023.122178

BibTeX
@article{McKenzie2023,
  author = {McKenzie, Nathalie D and Ahmad, Sarfraz and Awada, Ahmad and Kuhn, Theresa M and Recio, Fernando O and Holloway, Robert W},
  title = {Prognostic features of the tumor microenvironment in high-grade serous ovarian cancer and dietary immunomodulation},
  journal = {Life Sciences},
  year = {2023},
  doi = {10.1016/j.lfs.2023.122178}
}
Kostenlos starten →